OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 66 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 18.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $61,000 | 0.0% | 12,331 | 0.0% | 0.00% | – |
Q3 2016 | $61,000 | -3.2% | 12,331 | 0.0% | 0.00% | – |
Q2 2016 | $63,000 | -10.0% | 12,331 | 0.0% | 0.00% | – |
Q1 2016 | $70,000 | -45.3% | 12,331 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $128,000 | -43.9% | 12,331 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $228,000 | -5.0% | 12,331 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $240,000 | -2.0% | 12,331 | -11.4% | 0.00% | 0.0% |
Q1 2015 | $245,000 | +4.3% | 13,910 | -5.4% | 0.00% | 0.0% |
Q4 2014 | $235,000 | +28.4% | 14,701 | +1.0% | 0.00% | 0.0% |
Q3 2014 | $183,000 | -18.7% | 14,549 | +0.9% | 0.00% | 0.0% |
Q2 2014 | $225,000 | +33.1% | 14,415 | +12.1% | 0.00% | 0.0% |
Q1 2014 | $169,000 | -19.1% | 12,861 | -0.9% | 0.00% | 0.0% |
Q4 2013 | $209,000 | -4.6% | 12,980 | -1.6% | 0.00% | 0.0% |
Q3 2013 | $219,000 | +72.4% | 13,191 | +4.7% | 0.00% | 0.0% |
Q2 2013 | $127,000 | – | 12,603 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,240,709 | $23,259,000 | 3.12% |
PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $361,000 | 0.25% |
Freedom Investment Management, Inc. | 118,284 | $1,228,000 | 0.09% |
Spark Investment Management LLC | 62,800 | $651,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 98,901 | $1,027,000 | 0.05% |
Baker Brothers Advisors | 499,193 | $5,182,000 | 0.04% |
KILLEN GROUP INC | 31,000 | $322,000 | 0.03% |
GROUP ONE TRADING, L.P. | 127,263 | $1,321,000 | 0.02% |
A.R.T. Advisors, LLC | 27,049 | $280,000 | 0.01% |
QS Investors, LLC | 132,027 | $1,370,000 | 0.01% |